Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.060
-0.140 (-11.67%)
At close: Oct 9, 2026, 4:00 PM EDT
1.045
-0.015 (-1.42%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Lisata Therapeutics Employees
Lisata Therapeutics had 21 employees as of December 31, 2025. The number of employees decreased by 5 or -19.23% compared to the previous year. That makes Lisata Therapeutics the 38,189th largest employer in the world and 5,476th in the United States.
Employees
21
Change (1Y)
-5
Growth (1Y)
-19.23%
Revenue / Employee
$4,762
Profits / Employee
-$696,238
Market Cap
9.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 21 | -5 | -19.23% |
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | -2 | -7.41% |
| Dec 31, 2022 | 27 | 0 | - |
| Dec 31, 2021 | 27 | 3 | 12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Senti Biosciences Holdings | 39 |
| Theriva Biologics | 16 |
| CalciMedica | 15 |
| BioVie | 13 |
| Purple Biotech | 10 |
| Immuron | 8 |
| Adial Pharmaceuticals | 5 |
LSTA News
- 2 days ago - Lisata Therapeutics granted U.S. patent for certepetide in pancreatic cancer - TheFly
- 2 days ago - Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors - GlobeNewsWire
- 3 days ago - Lisata Therapeutics Proxy statement: Proxy filing - Filings
- 5 days ago - Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly - GlobeNewsWire
- 16 days ago - Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026 - GlobeNewsWire
- 23 days ago - Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement - GlobeNewsWire
- 2 months ago - Lisata Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Lisata Therapeutics provides update following termination of Kuva Labs merger - TheFly